NCT05810909View on ClinicalTrials.gov

Effects of Amorphous Calcium Carbonate Supplementation on Bone Health in Postmenopausal Women With Osteopenia

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

December 10, 2021

Study Completion Date

September 22, 2022

Conditions
CalciumOsteopeniaBone Mineral DensityBone Turnover Marker
Interventions
DIETARY_SUPPLEMENT

amorphous calcium carbonate/ Placebo

The dosage was 1000 mg calcium carbonate (400mg calcium element) per day, and placebo (calcium carbonate change to excipient)

Trial Locations (1)

110

Taipei Medical University, Taipei

All Listed Sponsors
collaborator

Taipei Medical University

OTHER

lead

Universal Integrated Corp.

INDUSTRY

NCT05810909 - Effects of Amorphous Calcium Carbonate Supplementation on Bone Health in Postmenopausal Women With Osteopenia | Biotech Hunter | Biotech Hunter